Lipella Pharmaceuticals Inc (NASDAQ:LIPO)’s traded shares stood at 1.58 million during the last session, with the company’s beta value hitting 0.41. At the close of trading, the stock’s price was $3.09, to imply an increase of 11.55% or $0.32 in intraday trading. The LIPO share’s 52-week high remains $12.00, putting it -288.35% down since that peak but still an impressive 28.48% since price per share fell to its 52-week low of $2.21. The company has a valuation of $3.74M, with an average of 0.13 million shares in intraday trading volume over the past 10 days and average of 176.03K shares over the past 3 months.
Lipella Pharmaceuticals Inc (NASDAQ:LIPO) trade information
After registering a 11.55% upside in the last session, Lipella Pharmaceuticals Inc (LIPO) has traded red over the past five days. The 5-day price performance for the stock is 4.75%, and 21.01% over 30 days. With these gigs, the year-to-date price performance is -62.13%. Short interest in Lipella Pharmaceuticals Inc (NASDAQ:LIPO) saw shorts transact 2273.0 shares and set a 0.01 days time to cover.
The extremes give us $2 and $2 for target low and target high price respectively. As such, LIPO has been trading 35.28% off suggested target high and 35.28% from its likely low.
LIPO Dividends
Lipella Pharmaceuticals Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Lipella Pharmaceuticals Inc (NASDAQ:LIPO)’s Major holders
Lipella Pharmaceuticals Inc insiders hold 29.37% of total outstanding shares, with institutional holders owning 0.88% of the shares at 1.24% float percentage. In total, 0.88% institutions holds shares in the company.
